G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients (G-Step)
Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer
Sponsor: National Cancer Institute, Naples
Listed as NCT00401609, this PHASE1/PHASE2 trial focuses on Small Cell Lung Cancer and remains completed. Sponsored by National Cancer Institute, Naples, it has been updated 6 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Nov 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute, Naples
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bari, Italy , Campobasso, Italy , Cosenza, Italy , Frosinone, Italy , Genova, Italy , Gorgonzola, Italy , Milan, Italy , Monteforte Irpino, Italy , Napoli, Italy , Noale, Italy and 6 more locations